Last reviewed · How we verify
Hyperpolarized He3
At a glance
| Generic name | Hyperpolarized He3 |
|---|---|
| Also known as | Helium study |
| Sponsor | University of Virginia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Upset Stomach/vomiting/gas
- Headache/sore throat
- Fever
Key clinical trials
- Study of Airflow in the Lungs Using Helium MRI (NA)
- Structure and Function MRI of Asthma (NA)
- Healthy Lung Study- Development of 3T MRI Hardware and Software for 3He Gas Imaging of the Lung: Healthy Volunteer Development Study
- Longitudinal 3He Magnetic Resonance Imaging of Healthy Lung (NA)
- Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders (EARLY_PHASE1)
- Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging (NA)
- Imaging and Understanding BOS in Lung Transplantation
- MRI for Non-Invasive Imaging in Neonates and Children (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hyperpolarized He3 CI brief — competitive landscape report
- Hyperpolarized He3 updates RSS · CI watch RSS
- University of Virginia portfolio CI